logo
Share SHARE
FONT-SIZE Plus   Neg

Reports: Pfizer Likely To Pick Buyer For Infant-nutrition Unit Next Week

Pharmaceutical giant Pfizer Inc. (PFE: Quote) is close to a deal to sell its infant-nutrition unit and an announcement could be made as early as next week, reports said Tuesday.

Switzerland-based Nestle SA (NSTR.L, NSRGY.PK) is said to be likely to win the bid for the unit that makes baby formula and maternal supplements, according to a report in the Wall Street Journal which said the deal price was at least $9 billion.

Pfizer had received bids from Nestle and France's Danone SA (DANOY.PK), each worth about $10 billion, Bloomberg said. Danone made a joint bid with Mead Johnson Nutrition Co. (MJN: Quote) and a third bidder is no longer in the running.

The report added that Danone said it is not likely to win the bid. Pfizer is said to be keeping Danone in the bidding process.

It was reported in February that Nestle and Danone were trying to overcome antitrust problems in the deal.

Meanwhile, Pfizer is said to be planning an initial public offering for its animal health unit. The drugmaker has hired JPMorgan Chase & Co., Bank of America Corp. and Morgan Stanley to aid in the transaction.

PFE closed Tuesday's regular trade at $22.31, up $0.33, on 29.1 million shares.

Nestle closed up by 1.33 percent at 56.75 Swiss francs on a volume of 6 million shares.

Danone settled in Paris higher by 2.90 percent at 53.08 euros on 3.36 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Electronic Arts Inc. (EA) on Tuesday reported an increase in profit for the fourth quarter, reflecting continued strong demand from gamers for titles compatible with new-gen consoles and better digital revenues, with both earnings and revenues topping Wall Street estimates. Redwood City, California-based... Daily deals site Groupon Inc said Tuesday after the markets closed that its first quarter loss narrowed from last year, as revenue increased and operating expenses fell. The company's quarterly earnings per share, excluding item, also came in above analysts' expectations, but its quarterly revenue fell short of analysts' forecast. Mylan reported a plunge in profit, hurt by acquisition costs and a stronger dollar. However, quarterly earnings topped Wall Street estimates, while sales missed expectations despite growth across all regions.
comments powered by Disqus
RELATED NEWS
Trade PFE now with 
Follow RTT